My Approach
I work with clarity, accountability, and agility alongside your cross-functional teams, helping them perform at their best while building pre-launch and launch strategies designed for ambitious, fast access to market in France and Belgium.
Over the years, I have built strong expertise in national and regional Access strategy — reimbursement, pricing negotiation, HEOR, RWE, and early access — with particular depth in oncology and immunology, alongside experience in rare diseases/orphan drugs and cardiovascular. My consulting background has given me the adaptability to move confidently across therapeutic areas and project types.
I believe strong Market Access outcomes are built on strong relationships. I actively cultivate partnerships with policymakers, key opinion leaders, institutions, and patient associations — because collaboration with these stakeholders is what ultimately improves patient access.
Founder